TSS
HAE icon

Two Sigma Securities’s Haemonetics HAE Stock Holding History

Two Sigma Securities’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Buy
+4,746
New +$305K 0.03% 757
2022
Q4 		– Sell
-2,996
Closed -$222K – 2851
2022
Q3 		$222K Buy
+2,996
New +$215K 0.01% 1856
2020
Q1 		– Sell
-2,218
Closed -$255K – 1730
2019
Q4 		$255K Buy
+2,218
New +$268K ﹤0.01% 1909

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Securities's HAE Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Haemonetics (HAE) in Q2 2026: 4,746 shares worth $356K. The stake represents 0.03% of the portfolio and ranks #757 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in HAE as recently as Q3 2022.

Two Sigma Securities first reported a position in HAE in Q4 2019 and has held it in 3 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Two Sigma Securities held 4,746 shares of Haemonetics worth $356K as of Q2 2026.
  • Haemonetics was a new Two Sigma Securities position in Q2 2026.
  • Haemonetics made up 0.03% of Two Sigma Securities's portfolio in Q2 2026, its #757 holding.
  • Two Sigma Securities first reported a position in Haemonetics in Q4 2019 and has held it in 3 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.